Trial Profile
"A Randomized, Parallel Group, Open Trial Examining the Safety, Efficacy and Tolerability of Fast Titration, 800mg/day by day 4, of Quetiapine Fumarate Compared to Standard Titration, 400mg/day by day 4, in the Treatment of Bipolar 1 Manic Episode.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Apr 2022
Price :
$35
*
At a glance
- Drugs Quetiapine (Primary)
- Indications Bipolar I disorders
- Focus Adverse reactions
- Sponsors AstraZeneca
- 07 Apr 2022 Status changed from recruiting to completed.
- 05 Sep 2011 New trial record